Requisite Capital Management, LLC Bristol Myers Squibb CO Transaction History

Requisite Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 14, 2020	SELL	$46.4 - $67.43 $357,280 - $519,211	-7,700 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$49.21 - $64.19 $541,310 - $706,090	-11,000 Reduced 58.82%	7,700 $494,000
Q2 2019 Aug 05, 2019	BUY	$44.62 - $49.34 $120,474 - $133,218	2,700 Added 16.88%	18,700 $848,000
Q1 2019 May 15, 2019	BUY	$45.12 - $53.8 $721,920 - $860,800	16,000 New	16,000 $763,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Requisite Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Requisite Capital Management, LLC with notifications on news.